Incidence and predictors of groin complications early after coronary artery intervention: a prospective observational

Maan Sh Al-Momani1, Mohannad Eid AbuRuz2

  • 11Royal Medical Services, Amman, Jordan.

BMC Nursing
|July 13, 2019
PubMed

Insights

Groin complications after percutaneous coronary intervention (PCI) affect 38% of patients. Identifying high-risk groups, such as females and those with high blood pressure, can help manage these common PCI complications.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) is a leading cause of global mortality.
  • Percutaneous coronary intervention (PCI) is a common treatment for CAD but carries risks.
  • Groin complications are potential adverse events following PCI procedures.

Purpose of the Study:

  • To determine the incidence rate of groin complications post-PCI.
  • To identify predictors of groin complications in patients undergoing PCI.
  • To analyze these factors within cardiac catheterization laboratories in Jordan.

Main Methods:

  • Prospective observational study of 300 patients undergoing PCI.
  • Data collected via a pre-structured observational sheet.
  • Logistic regression analysis used to identify correlated variables and predictors.

Main Results:

  • 38% of patients (114/300) experienced groin complications, most commonly ecchymosis (34%).
  • Females and patients over 65 were twice as likely to develop complications (OR=2.13-2.14).
  • Systolic blood pressure >180 mmHg before sheath removal increased complication risk tenfold (OR=9.82).

Conclusions:

  • Several factors increase the risk of groin complications after PCI.
  • Identifying high-risk patients, including females, is crucial for targeted prevention strategies.
  • Implementing specific interventions for at-risk groups may reduce complication rates.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
10.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.6K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342